Covid-19: Pfizer Vaccine Works Against Indian Variant — Co-founder

'Dotun Akintomide
Writer
Why Africa May Be Left Behind In Covid-19 Vaccination - WHO

Ad

PENGASSAN-Dangote war: Nigeria lost billions of naira, 16% oil output, 30% gas sale, -NNPC

By Obinna Uballa The Nigerian National Petroleum Company Limited (NNPCL) has revealed that the recent three-day strike by the Petroleum and Natural Gas Senior Staff Association of Nigeria (PENGASSAN) caused 16 percent of national oil production, 30 percent of marketed gas, and 20 percent of power supply to be lost, putting severe pressure on the…

OpenAI seals $6.6bn share deal of $500bn, outpaces SpaceX

By Obinna Uballa OpenAI has completed a $6.6 billion secondary share sale, valuing the company at a staggering $500 billion, according to an insider familiar with the deal, CNBC reported on Thursday. The transaction allowed current and former employees to sell shares, solidifying OpenAI’s position as the world’s most valuable private company, overtaking SpaceX’s $456…

US shutdown won’t affect visa, passport services in Nigeria – Embassy

By Obinna Uballa The United States Embassy in Nigeria has reassured applicants that visa and passport services will continue uninterrupted, despite the ongoing partial shutdown of the US government. In a notice issued Wednesday via its official X handle, the embassy said: “Due to the lapse in appropriations, this X account will not be updated…

Ad

BioNTech co-founder and a German Oncologist, Ugur Sahin on Wednesday, has admitted that the vaccine that his company jointly developed with Pfizer works against the Indian variant of Covid-19.

According to Sahin, investigations revealed that the Pfizer-BioNTech vaccine works against the B.1.617 COVID-19 variant in India.

The Pfizer-BioNTech vaccine was developed by BioNTech, a German Company and Pfizer, an American Company.

The BioNTech-Pfizer vaccine was the first to win authorisation and has since been deployed to several countries.

According to Sahin, after series of tests conducted in India, it was discovered that the vaccine works against some victims of the B.1.617 variant in India.

In his words, “We are still testing the Indian variant, but the Indian variant has mutations that we have already tested for and which our vaccine works against, so I am confident,” said Sahin.

“The vaccine is cleverly built and I’m convinced the bulwark will hold. And if we have to strengthen the bulwark again, then we will do it, that I’m not worried about,” he added.

India is currently facing another spike of Covid-19 cases. There are also fears that a new variant could be the reason for the surging new cases of the virus.

According to the data obtained from the Union Health Ministry of India, a total of 360,960 COVID-19 cases, recording fresh fatalities of 3,293, was recorded on Wednesday. The total tally of India’s COVID-19 cases stands at 17,997,267 with 201,187 deaths, as of Wednesday.

The World Health Organization has said the B.1.617 variant of Covid-19 first found in India has been detected in at least 17 countries.

Ad

Unlocking Opportunities in the Gulf of Guinea during UNGA80
X whatsapp